Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDG-PET/CT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04622631
What this trial is testing

Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT

Who this might be right for
Neuroendocrine Tumors
Dr. Nayruz Knaana 80
Not applicableStudy completedNCT06170151
What this trial is testing

Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma

Who this might be right for
Multiple Myeloma
IRCCS San Raffaele 10
Not applicableStudy completedNCT02476734
What this trial is testing

FDG-PET/CT Imaging as Early Predictor of DP

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 9
Not applicableStudy completedNCT06171464
What this trial is testing

Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
IRCCS San Raffaele 19
Not applicableUnknownNCT03015298
What this trial is testing

Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer

Who this might be right for
Gastric Cancer Stage
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07733024
What this trial is testing

Comparing DLL3 PET/CT to Standard Scans in Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Tumors
Tingting Yuan 200
Not applicableStudy completedNCT02232724
What this trial is testing

Choline PET/CT vs. Dual Time Point FDG PET/CT in Prostate Cancer

Who this might be right for
Prostate Cancer
Odense University Hospital 20
Not applicableWithdrawnNCT02958358
What this trial is testing

FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan

Who this might be right for
Pulmonary Arterial Hypertension
Robert Scott Harris, M.D.
Not applicableStudy completedNCT05113576
What this trial is testing

Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 132
Testing effectiveness (Phase 2)UnknownNCT02805608
What this trial is testing

UPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
Rigshospitalet, Denmark 40
Not applicableWithdrawnNCT02919332
What this trial is testing

Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioma
Jonsson Comprehensive Cancer Center
Post-approval studies (Phase 4)Study completedNCT01553058
What this trial is testing

Vascular Inflammation in Psoriasis Trial (The VIP Trial)

Who this might be right for
PsoriasisCardiovascular Disease
University of Pennsylvania 97
Not applicableStudy completedNCT01691300
What this trial is testing

C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT

Who this might be right for
Multiple Myeloma
Chang Gung Memorial Hospital 30
Early research (Phase 1)Looking for participantsNCT05747625
What this trial is testing

(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaStage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck
Eben Rosenthal 60
Very early researchStudy completedNCT03048097
What this trial is testing

Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82

Who this might be right for
Sarcoidosis
Yale University 15
Not applicableStudy completedNCT06919159
What this trial is testing

Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate-specific Membrane AntigenPositron Emission Tomography (PET)
Jiequn Yu 45
Early research (Phase 1)Study completedNCT00959582
What this trial is testing

Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Merck Sharp & Dohme LLC 42
Not applicableUnknownNCT02855190
What this trial is testing

Comparative Study With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection

Who this might be right for
Infection and Inflammatory Reaction Due to Internal Joint Prosthesis
Chang Gung Memorial Hospital 30
Not applicableUnknownNCT05806333
What this trial is testing

[18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity

Who this might be right for
Liver Cancer
Jilin University 60
Not applicableEnrolling By InvitationNCT05110443
What this trial is testing

A Comparison of Static and Dynamic PET/CT (HYPOTHESIS Generation Study)

Who this might be right for
OncologyInfectionsInflammation
Aarhus University Hospital 500
Next Page